These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 33738519

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The image quality, lesion detectability, and acquisition time of 18F-FDG total-body PET/CT in oncological patients.
    Zhang YQ, Hu PC, Wu RZ, Gu YS, Chen SG, Yu HJ, Wang XQ, Song J, Shi HC.
    Eur J Nucl Med Mol Imaging; 2020 Oct; 47(11):2507-2515. PubMed ID: 32424483
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Defining optimal tracer activities in pediatric oncologic whole-body 18F-FDG-PET/MRI.
    Gatidis S, Schmidt H, la Fougère C, Nikolaou K, Schwenzer NF, Schäfer JF.
    Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2283-2289. PubMed ID: 27565153
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Simulated Reduced-Count Whole-Body FDG PET: Evaluation in Children and Young Adults Imaged on a Digital PET Scanner.
    Alves VPV, Brady S, Ata NA, Li Y, MacLean J, Zhang B, Sharp SE, Trout AT.
    AJR Am J Roentgenol; 2022 Dec; 219(6):952-961. PubMed ID: 35731102
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Head-to-head intra-individual comparison of total-body 2-[18F]FDG PET/CT and digital PET/CT in patients with malignant tumor: how sensitive could it be?
    Chen X, Hu P, Yu H, Tan H, He Y, Cao S, Zhou Y, Shi H.
    Eur Radiol; 2023 Nov; 33(11):7890-7898. PubMed ID: 37338551
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A third of the radiotracer dose: two decades of progress in pediatric [18F]fluorodeoxyglucose PET/CT and PET/MR imaging.
    Waelti S, Skawran S, Sartoretti T, Schwyzer M, Gennari AG, Mader C, Treyer V, Kellenberger CJ, Burger IA, Hany T, Maurer A, Huellner MW, Messerli M.
    Eur Radiol; 2024 May; 34(5):3252-3259. PubMed ID: 37855853
    [Abstract] [Full Text] [Related]

  • 17. Ultralow-dose [18F]FDG PET/CT imaging: demonstration of feasibility in dynamic and static images.
    Tan H, Qi C, Cao Y, Cai D, Mao W, Yu H, Sui X, Liu G, Shi H.
    Eur Radiol; 2023 Jul; 33(7):5017-5027. PubMed ID: 36688971
    [Abstract] [Full Text] [Related]

  • 18. Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low 18F-FDG Activity.
    Hu Y, Liu G, Yu H, Wang Y, Li C, Tan H, Chen S, Gu J, Shi H.
    J Nucl Med; 2022 Jun; 63(6):959-965. PubMed ID: 34593593
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Simulation of Tracer Dose Reduction in 18F-FDG PET/MRI: Effects on Oncologic Reading, Image Quality, and Artifacts.
    Seith F, Schmidt H, Kunz J, Küstner T, Gatidis S, Nikolaou K, la Fougère C, Schwenzer N.
    J Nucl Med; 2017 Oct; 58(10):1699-1705. PubMed ID: 28360205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.